Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings

Allscripts Healthcare: Q4 Earnings Insights

By Benzinga Insights
Today, 4:14 PM
Allscripts Healthcare (NASDAQ:MDRX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

MDRX

Read More
1 minute read
  • Earnings
  • News

Allscripts Healthcare Q4 EPS $0.79 May Not Compare To $0.32 Estimate, Sales $392.00M Beat $391.10M Estimate

By Benzinga Newsdesk
Today, 4:14 PM
Allscripts Healthcare (NASDAQ:MDRX) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.32 by 146.88 percent. This is a 172.41 percent increase over earnings of $0.29 per share

MDRX

Read More
3 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

28 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin
Today, 4:14 PM
Gainers

AJRD

Read More
1 minute read
  • M&A
  • Media
  • Movers
  • News
  • Tech
  • Trading Ideas

Cerner Shares Soar As Oracle Eyes Healthcare Foray By Takeover: Bloomberg

By Anusuya Lahiri
Today, 4:14 PM
Shares of Cerner Corp (NASDAQ: CERN) gained momentum on a potential takeover by Oracle Corp (NYSE: ORCL), 

AMZN

Read More
1 minute read
  • Earnings
  • News

Allscripts Healthcare Q3 EPS $0.12 Misses $0.18 Estimate

By Benzinga Newsdesk
Today, 4:14 PM
Allscripts Healthcare (NASDAQ:MDRX) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.18 by 33.33 percent. This is a 40 percent decrease over earnings of $0.20 per share

MDRX

Read More
32 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook

Earnings Scheduled For November 4, 2021

By Benzinga Insights
Today, 4:14 PM
  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

Read More
2 minute read
  • FDA
  • News

Allscripts Launches Guided Scheduling, Leveraging Artificial Intelligence To Improve Patient Care And Increase Healthcare Operational Efficiencies

By Benzinga Newsdesk
Today, 4:14 PM
Allscripts (NASDAQ MDRX) Guided Scheduling, launching in Allscripts Practice Management, is an artificial intelligence scheduling application that uses real-time provider, practice, and industry data to optimize

MDRX

Read More
2 minute read
  • Contracts
  • News

Allscripts Healthcare Solutions’ Business Unit Veradigm Partners With CareMetx; Terms Not Disclosed

By Benzinga Newsdesk
Today, 4:14 PM
Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ:MDRX), and CareMetx, a leading technology-enabled hub services company focused

MDRX

Read More
2 minute read
  • Earnings

Looking into Allscripts Healthcare’s Return on Capital Employed

By Benzinga Insights
Today, 4:14 PM
Pulled from Benzinga Pro data Allscripts Healthcare (NASDAQ:MDRX) posted a 22.23% decrease in earnings from Q1. Sales, however, increased by 1.44% over the previous quarter to $373.70 million.

MDRX

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
Today, 4:14 PM
Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value of their outstanding shares is at $29.3 million.

AQB

Posts navigation

Previous 1 2 3 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service